Literature DB >> 9065882

New combination for the therapy of canine otitis externa. I. Microbiology of otitis externa.

G Kiss1, S Radványi, G Szigeti.   

Abstract

In order to compound a new drug combination against canine otitis externa (OE), 515 dogs affected with OE were subjected to physical examination and microbiological analysis of their ear exudates. OE was erythematous-ceruminous in 83 per cent and suppurative in 17 per cent of the patient material. Erythematous-ceruminous inflammations were characterised by severe pruritus and accumulation of brownish, greasy cerumen in the auditory canal. The yeast Malassezia pachydermatis was isolated from the ears of 76 per cent of the dogs, often in combination with Staphylococcus intermedius bacteria. M pachydermatis showed the most sensitivity, in decreasing order of efficacy, to ketoconazole, econazole, clotrimazole, miconazole and nystatin. S intermedius isolates were most sensitive to amoxycillin-clavulanic acid, enrofloxacin, cephalexin and gentamicin. The microorganism most frequently isolated from dogs with suppurative OE was Pseudomonas aeruginosa; in some cases Proteus, Streptococcus and Pasteurella were also isolated. The P aeruginosa isolates showed the highest sensitivity to gentamicin, polymyxin B and tobramycin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065882     DOI: 10.1111/j.1748-5827.1997.tb02987.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  13 in total

1.  New nystatin polymeric complexes and their in vitro antifungal evaluation in a model study with Fusarium oxysporum.

Authors:  Ekatherina Charvalos; Aristeidis Tsatsakis; Manolis Tzatzarakis; George Dolapsakis; John Stiakakis
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

2.  Update on antimicrobial susceptibilities of bacterial isolates from canine and feline otitis externa.

Authors:  Harry Hariharan; Mada Coles; Doris Poole; Lorraine Lund; Robert Page
Journal:  Can Vet J       Date:  2006-03       Impact factor: 1.008

3.  In vivo efficacy study of the anti-inflammatory properties of Surolan.

Authors:  Anna Bolinder; Kelly Cameron; Lynn Faubert; Jeff Wilson; Jeff Aramini; Jonathan Hare
Journal:  Can J Vet Res       Date:  2006-07       Impact factor: 1.310

4.  Epidemiological study of dogs with otitis externa in Cape Breton, Nova Scotia.

Authors:  Laura R Perry; Bernard MacLennan; Rebecca Korven; Timothy A Rawlings
Journal:  Can Vet J       Date:  2017-02       Impact factor: 1.008

5.  Identification and antimicrobial susceptibility patterns of bacteria causing otitis externa in dogs.

Authors:  Hamed Zamankhan Malayeri; Shahram Jamshidi; Taghi Zahraei Salehi
Journal:  Vet Res Commun       Date:  2010-06-05       Impact factor: 2.459

6.  Agar Diffusion Procedures for Susceptibility Testing of Malassezia pachydermatis: Evaluation of Mueller-Hinton Agar Plus 2 % Glucose and 0.5 µg/ml Methylene Blue as the Test Medium.

Authors:  M Pasquetti; E Chiavassa; P Tizzani; P Danesi; A Peano
Journal:  Mycopathologia       Date:  2015-07-03       Impact factor: 2.574

7.  Comparative study of the microbial profile from bilateral canine otitis externa.

Authors:  Lis C Oliveira; Carlos A L Leite; Raimunda S N Brilhante; Cibele B M Carvalho
Journal:  Can Vet J       Date:  2008-08       Impact factor: 1.008

8.  Evaluation of a single-administration ototopical treatment for canine otitis externa: a randomised trial.

Authors:  John Blake; Daniel Keil; Kenneth Kwochka; Kathleen Palma; Jennifer Schofield
Journal:  Vet Rec Open       Date:  2017-11-14

9.  Synergistic effects of miconazole and polymyxin B on microbial pathogens.

Authors:  Silvia Pietschmann; Katrin Hoffmann; Michael Voget; Ulrich Pison
Journal:  Vet Res Commun       Date:  2008-12-16       Impact factor: 2.459

10.  Determination of N-acylhomoserine lactones of Pseudomonas aeruginosa in clinical samples from dogs with otitis externa.

Authors:  Darja Kušar; Karin Šrimpf; Petra Isaković; Lina Kalšek; Javid Hosseini; Irena Zdovc; Tina Kotnik; Modest Vengušt; Gabrijela Tavčar-Kalcher
Journal:  BMC Vet Res       Date:  2016-10-18       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.